我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

多发性肌炎并发心包积液的临床特点及相关因素

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2016年第4期
页码:
450-453
栏目:
临床研究
出版日期:
2016-04-01

文章信息/Info

Title:
Clinical features and relative factors of pericardial effusion in polymyositis
作者:
汪 汉; 罗 莲; 杨萌萌; 刘汉雄; 余秀琼; 王引利; 蔡 琳
(成都市心血管病研究所、成都市第三人民医院心内科，四川 成都 610031)
Author(s):
WANG Han;  LUO Lian;  YANG Meng-meng;  LIU Han-xiong;  YU Xiu-qiong;  WANG Yin-li;  CAI Lin
(Cardiovascular Disease Research Institute, China Chest Pain Center, Chengdu Third People’s Hospital, Chengdu 610031, Sichuan, China)
关键词:
多发性肌炎; 心包积液; 相关因素; 超声心动图
Keywords:
polymyositis;  pericardial effusion;  relative factors;  echocardiography
分类号:
R542.1
DOI:
-
文献标识码:
A
摘要:
目的 观察和分析多发性肌炎并发心包积液患者的临床特点及相关因素。方法 纳入106例多发性肌炎患者，记录患者一般信息、临床情况、实验室检查，并运用超声心动图对心包积液患者进行半定量分析，logistic回归被用于评估心包积液的影响因素。结果 106例多发性肌炎患者中并发心包积液18例，占17.0%，并发少量、中量及大量心包积液的多发性肌炎比例分别为：67%、28%和6%；logistic回归显示心率(OR=1.050，95%CI 1.001-1.102)、主肺动脉内径(OR=1.270，95%CI 1.015-1.589)以及存在间质性肺病(OR=5.274，95%CI 1.507-18.460)可能与多发性肌炎并发心包积液相关。结论 多发性肌炎并发心包积液并不少见，多为少到中量积液；心包积液主要与患者心率、主肺动脉内径以及并存的间质性肺病相关。
Abstract:
AIM To assess the clinical features and relative factors of pericardial effusion in polymyositis. METHODSOne hundred and six patients with polymyositis from our cardiovascular disease research institute were included in this study. Routine information, clinical features and laboratory parameters of these patients were analyzed. Echocardiography was used to evaluate pericardial effusion. Binary logistic regression was used to assess the risk factors of pericardial effusion in polymyositis. RESULTSEighteen patients (17.0%) of the 106 polymyositis patients had pericardial effusion. Frequency of small, moderate, and large amounts of pericardial effusion in polymyositis was 67%, 28% and 6%, respectively. Logistic regression model demonstrated that heart rate (OR=1.050, 95%CI 1.001-1.102), interstitial lung disease (OR=5.274, 95%CI 1.507-18.460) and main pulmonary artery diameter (OR=1.270, 95%CI 1.015-1.589) were associated with pericardial effusion in polymyositis. CONCLUSIONPericardial effusion may be common in polymyositis, usually presenting with small or moderate amounts of pericardial effusion. Pericardial effusion is often associated with heart rate, interstitial lung disease and main pulmonary artery diameter in polymyositis.

参考文献/References

[1]Wang H,Cai Y,Cai L,et al.Altered lipid levels in untreated patients with early polymyositis[J].PLoS One,2014,9(2):e89827.
[2]中华医学会风湿病学分会.多发性肌炎和皮肌炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(12):828-831.
[3]Bohan A,Peter JB.Polymyositis and dermatomyositis[J].N Engl J Med,1975,292(7):344-347.
[4]王新房.超声心动图学[M].第四版,北京:人民卫生出版社,2009:464-465.
[5]Lu Z,Guo-chun W,Li M,et al.Cardiac Involvement in Adult Polymyositis or dermatomyositis: A Systematic Review[J].Clin Cardiol,2012,35(11):685-691.
[6]Lai YT,Dai YS,Yen MF,et al.Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events:a Taiwanese population-based longitudinal follow-up study[J].Br J Dermatol,2013,168(5):1054-1059.
[7]Gupta R,Wayangankar SA,Targoff IN,et al.Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review[J].Int J Cardiol,2011,148(3):261-270.
[8]汪 汉,蔡 琳.多发性肌炎/皮肌炎的心脏病变[J].心血管病学进展,2015,36(3):332-337.
[9]Khoueiry Z,Roubille C,Nagot N,et al.Could heart rate play a role in pericardial inflammation?[J].Med Hypotheses,2012,79(4):512-515.
[10]Hallowell RW,Ascherman DP,Danoff SK.Pulmonary manifestations of polymyositis/dermatomyositis[J].Semin Respir Crit Care Med,2014,35(3):239-248.
[11]Sugiura T,Iwasaka T,Takehana K,et al.Disturbance of pulmonary gas exchange in patients with acute myocardial infarction-associated pericardial effusion[J].Am J Cardiol,1993,72(2):162-164.
[12]Sahay S,Tonelli AR.Pericardial effusion in pulmonary arterial hypertension[J].Pulm Circ,2013,3(3):467-477.
[13]Fischer A,Misumi S,Curran-Everett D,et al.Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease[J].Chest,2007,131(4):988-992.
[14]Diógenes MS,de Carvalho VB,Rozov T,et al.Pericardial effusion due to pulmonary lymphangiectasis[J].Arq Bras Cardiol,1988,51(2):185-192.
[15]孔 彬,黄 鹤,于胜波,等.慢性心力衰竭合并心包积液患者危险因素分析[J].中华老年多器官疾病杂志,2011,10(5):416-419.

备注/Memo

备注/Memo:
收稿日期：2015-06-10.
基金项目：国家自然科学基金青年基金资助(81300243)；四川省医学科研青年创新课题资助(Q14013)
通讯作者：蔡琳，教授，主要从事心脏介入研究 Email：caiwm@163.com
作者简介：汪汉，副主任医师，博士 Email：384198970@qq.com
更新日期/Last Update: 2016-04-01